Welcome!

News Feed Item

Web Tool Highlights Ongoing Impact of Tuberculosis in the United States

Aeras releases TB Crisis Tracker on World TB Day

ROCKVILLE, Md., March 24, 2014 /PRNewswire/ -- The tuberculosis epidemic continues to impact pockets of the U.S. population, according to a data visualization tool developed by the nonprofit biotech, Aeras.  Launched on World TB Day, Aeras's TB Crisis Tracker illustrates how the TB epidemic continues to impact the U.S.

"TB's impact in the U.S. is but a fraction of what it once was, but the Aeras TB Crisis Tracker starkly demonstrates that TB is not a disease of the past, or limited to the poorest countries in the world, but rather one that can strike anywhere, in any population, and at any time," said Kari Stoever, Vice President for External Affairs at Aeras. "This tool provides a powerful reminder that a reported case of TB represents more than just a number on a disease ledger. Each TB case represents a human being, with a name, a face, a story, and a community at risk for exposure."

Often thought to be a disease of the past, TB none-the-less remains a disease of the present, both around the world and in the United States. TB kills 1.3 million people each year, and drug-resistant strains of the disease are making it more difficult and costly to treat. The number of new TB cases occurring in the United States is at an all-time low, but with an increasing proportion of domestic cases occurring among foreign-born residents, the domestic burden of disease is becoming increasingly linked with the global TB epidemic. Until TB is eliminated globally, it will remain a public health threat in the U.S., particularly among at-risk groups, including international travelers, health care workers, first responders and those who work with prisoners and the homeless.

The Tracker highlights a sampling of recent U.S. TB cases occurring in schools, hospitals and other settings that have generated media attention over the past year.  Aeras's goal is to use this tool to raise awareness about the ongoing impact of TB and bring more transparency and attention to reports of TB outbreaks in the U.S. 

The most effective way to stop an epidemic like TB is to prevent its spread. As with every other major infectious disease in the history of mankind, prevention through vaccination can be the most cost-effective tool in eradicating disease burden. Existing TB treatment and control programs are essential to controlling the disease and minimizing its health impact, but innovative new tools like an effective vaccine will be necessary to get ahead of transmission and drive game-changing reductions in disease burden.

"Most people I speak to in the U.S. think they are already vaccinated against TB," notes Ms. Stoever, "but what they believe to be a vaccine is more than likely just the skin test commonly used to check whether a person has been infected with the TB bacteria." The existing TB vaccine – Bacille Calmette–Guerin, or BCG – protects children from some severe forms of TB, but it is unreliable in preventing infectious TB in adolescents and adults – the primary transmitters of the disease – and is not recommended for use in the United States. New, effective TB vaccines would provide the ultimate solution to the epidemic, transforming the effort against this disease by protecting vulnerable populations in the U.S. and around the world from TB's devastating impact.

Scientific progress in TB vaccine R&D is well underway, and investments of more than $600 million over the past decade have produced a robust portfolio of TB vaccine candidates, with more than a dozen candidates currently in clinical trials. Partnerships and collaborations are crucial to advancing the development of these candidates: no one organization or institution can do this alone. Governments, researchers and industry partners from around the world have contributed to the progress that has been made to date, but mobilizing additional partners and resources will be essential to sustaining progress in the field. Expanded contributions from new and existing partners like the U.S. government can help ensure that new TB vaccines are developed as quickly and efficiently as possible.

View the TB Crisis Tracker at www.aeras.org/tbtracker.

About Aeras
Aeras is a nonprofit biotech advancing the development of tuberculosis vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras receives funding from Australian AID, the Bill & Melinda Gates Foundation, the UK Department for International Development, the Netherlands' Ministry of Foreign Affairs, and a range of other governments. Aeras is based in Rockville, Maryland; Cape Town, South Africa; and Beijing, China. www.aeras.org

SOURCE Aeras

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
Join IBM November 1 at 21st Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA, and learn how IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Cognitive analysis impacts today’s systems with unparalleled ability that were previously available only to manned, back-end operations. Thanks to cloud processing, IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Imagine a robot vacuum that becomes your personal assistant tha...
Your homes and cars can be automated and self-serviced. Why can't your storage? From simply asking questions to analyze and troubleshoot your infrastructure, to provisioning storage with snapshots, recovery and replication, your wildest sci-fi dream has come true. In his session at @DevOpsSummit at 20th Cloud Expo, Dan Florea, Director of Product Management at Tintri, provided a ChatOps demo where you can talk to your storage and manage it from anywhere, through Slack and similar services with...
Containers are rapidly finding their way into enterprise data centers, but change is difficult. How do enterprises transform their architecture with technologies like containers without losing the reliable components of their current solutions? In his session at @DevOpsSummit at 21st Cloud Expo, Tony Campbell, Director, Educational Services at CoreOS, will explore the challenges organizations are facing today as they move to containers and go over how Kubernetes applications can deploy with lega...
In their session at @DevOpsSummit at 21st Cloud Expo, Michael Berman, VP Engineering at TidalScale, and Ivo Jimenez, Engineer at TidalScale, will describe how automating tests in TidalScale is easy thanks to WaveRunner. They will show how they use WaveRunner, Jenkins, and Docker to have agile delivery of TidalScale. Michael Berman is VP Engineering at TidalScale. TidalScale is developing a scale up compute and resource architecture for customers to perform big data exploration and real time anal...
I think DevOps is now a rambunctious teenager - it's starting to get a mind of its own, wanting to get its own things but it still needs some adult supervision," explained Thomas Hooker, VP of marketing at CollabNet, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"MobiDev is a software development company and we do complex, custom software development for everybody from entrepreneurs to large enterprises," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"With Digital Experience Monitoring what used to be a simple visit to a web page has exploded into app on phones, data from social media feeds, competitive benchmarking - these are all components that are only available because of some type of digital asset," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
The “Digital Era” is forcing us to engage with new methods to build, operate and maintain applications. This transformation also implies an evolution to more and more intelligent applications to better engage with the customers, while creating significant market differentiators. In both cases, the cloud has become a key enabler to embrace this digital revolution. So, moving to the cloud is no longer the question; the new questions are HOW and WHEN. To make this equation even more complex, most ...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
Learn how to solve the problem of keeping files in sync between multiple Docker containers. In his session at 16th Cloud Expo, Aaron Brongersma, Senior Infrastructure Engineer at Modulus, discussed using rsync, GlusterFS, EBS and Bit Torrent Sync. He broke down the tools that are needed to help create a seamless user experience. In the end, can we have an environment where we can easily move Docker containers, servers, and volumes without impacting our applications? He shared his results so yo...
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discussed how a new approach is neces...
"This week we're really focusing on scalability, asset preservation and how do you back up to the cloud and in the cloud with object storage, which is really a new way of attacking dealing with your file, your blocked data, where you put it and how you access it," stated Jeff Greenwald, Senior Director of Market Development at HGST, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
"ZeroStack is a startup in Silicon Valley. We're solving a very interesting problem around bringing public cloud convenience with private cloud control for enterprises and mid-size companies," explained Kamesh Pemmaraju, VP of Product Management at ZeroStack, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...